Ilyang Pharmaceutical Co.,Ltd (KRX:007570)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,400
+100 (0.81%)
At close: Sep 3, 2025
0.81%
Market Cap230.52B
Revenue (ttm)276.35B
Net Income (ttm)10.94B
Shares Out17.92M
EPS (ttm)608.86
PE Ratio21.12
Forward PEn/a
Dividend150.00 (1.17%)
Ex-Dividend DateDec 27, 2024
Volume20,525
Average Volume17,288
Open12,300
Previous Close12,300
Day's Range12,250 - 12,400
52-Week Range9,540 - 15,490
Beta0.51
RSI50.80
Earnings DateAug 13, 2025

About KRX:007570

Ilyang Pharmaceutical Co.,Ltd operates as a pharmaceutical company primarily in South Korea. The company offers anticancer, circulatory system, endocrine/metabolism, cheonjiyang, female hormone, urinary system, ophthalmology, liver disease, anti-inflammatory analgesic, digestive system, dermatology, respiratory system, nutrient infusion, and neurology medicines. It also provides antibiotics, antifungal drugs, anti-inflammatory analgesic drugs, insecticides, and vaccines; and health drinks, daily food, supplements, health food, cosmetics, and be... [Read more]

Sector Healthcare
Founded 1946
Employees 666
Stock Exchange Korea Stock Exchange
Ticker Symbol 007570
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.